GMP comment period extended
This article was originally published in The Tan Sheet
The public comment period on a proposed rule allowing exemptions from 100 percent identity testing requirements in the dietary supplements good manufacturing practices final rule is extended to Oct. 24, FDA says in a Sept. 17 Federal Register notice. FDA responded to requests from parties calling for more time to comment. FDA published the testing exemption IFR and the GMP final rule in June (1"The Tan Sheet" June 25, 2007, p. 3)...
You may also be interested in...
House Energy and Commerce Committee Chairman John Dingell is questioning allowing exemptions from 100 percent identity testing requirements for dietary supplement ingredients in light of mounting food safety issues
The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.
Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.